Combined inhibition of MEK and Plk1 has synergistic anti-tumor activity in NRAS mutant melanoma

por Posch, C, Cholewa, BD, Vujic, I, Sanlorenzo, M, Ma, J, Kim, ST, Kleffel, S, Schatton, T, Rappersberger, K, Gutteridge, R, Ahmad, N, Ortiz/Urda, S
Publicado 2015